BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
NCT00061880
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Lymphoma
Interventions
DRUG:
forodesine hydrochloride
Sponsor
BioCryst Pharmaceuticals